Alimohammad Moradi

Alimohammad Moradi

Auto-generated profile, based on publicly available information

Alimohammad Moradi

Department of General Surgery, Division of Hepato-Pancreato-Biliary and Transplantation Surgery, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2024 in Clinical Case Reports
Verified
Journal Article
Open access
AHAmirhossein Heidari
Amirhossein Heidari
YGYekta Ghane
Yekta Ghane
NHNazila Heidari
Nazila Heidari
AKAmir Kasraianfard
Amir Kasraianfard
MKMahsa Kargar
Mahsa Kargar
AMAli Mohammad Moradi
Ali Mohammad Moradi
Key Clinical Message: Cystic artery pseudoaneurysm is a rare phenomenon associated with cholecystitis. We describe the successful management of angioembolisation and cholecystectomy. Cystic artery pseudoaneurysm (CAP) is a rare but clinically significant condition with various etiological factors. Cholecystitis is a prominent cause, often leading to inflammation‐induced arterial wall erosion and pseudoaneurysm formation. CAP can present with a range of symptoms, including hemobilia, upper GI bleeding, and jaundice. Despite its rarity, CAP warrants attention in emergency care due to its potential for life‐threatening arterial bleeding. Timely diagnosis is crucial, with imaging techniques playing a key role. Depending on the clinical context, management options include endovascular embolization and surgical intervention. Due to the limited cases, standard protocols remain elusive. A 64‐year‐old woman presented with abdominal pain, anorexia, and weight loss, prompting an evaluation for possible gallbladder cancer. She experienced sudden abdominal pain and upper gastrointestinal bleeding (hematemesis). Laboratory findings revealed leukocytosis, anemia, and abnormal liver function tests. Imaging showed gallbladder wall thickening, luminal contraction, and a pseudoaneurysm in the cystic artery. The patient underwent angioembolization followed by cholecystectomy, confirming acute cholecystitis and CAP with thrombosis. This case underscores the importance of early recognition and appropriate management in CAP, particularly when accompanied by acute cholecystitis.

10 September 2025 in Endocrinology, Diabetes & Metabolism
Verified
Journal Article
Open access
YRYekta Rameshi
Yekta Rameshi
SDSimin Dashti‐Khavidaki
Simin Dashti‐Khavidaki
SRSoghra Rabizadeh
Soghra Rabizadeh
MAMahta Alimadadi
Mahta Alimadadi
AMAlimohammad Moradi
Alimohammad Moradi
ZAZahra Ahmadinejad
Zahra Ahmadinejad
Introduction: Liver transplantation is associated with various metabolic disorders. Peri‐transplant hyperglycemia is among the most frequent metabolic disorders among liver transplant recipients. Hyperglycemia following liver transplantation can increase the risk of post‐transplant complications, potentially impacting both graft and recipient outcomes. Several studies have compared intensive with standard blood glucose control strategies in liver transplant recipients. However, a comprehensive protocol for managing peri‐transplant hyperglycemia remains elusive. This review aimed to synthesise existing literature on the mechanisms, associated factors, and consequences of hyperglycemia after liver transplantation, and to provide recommendations for managing hyperglycemia in this patient population. Method: PubMed, Scopus, and UpToDate databases and American Diabetes Association guidelines were searched without time limitations until February 2025. Results: Peri‐liver transplant hyperglycemia can be attributed to several factors, including post‐reperfusion hepatocyte injury, insulin resistance stemming from underlying liver disease, surgical stress, and the use of immunosuppressive drugs. Various factors associated with peri‐transplant hyperglycemia can be categorised into pre‐transplant recipient factors, intraoperative factors, and donor‐related factors. Research has shown that inadequate glycemic control during the peri‐transplant period may have detrimental effects on post‐transplant outcomes, including an increased incidence of infections, graft rejection, acute kidney injury, prolonged hospital stays, and higher overall mortality. Conclusion: The suggestions presented in this article, which consider the recipient's medical history and clinical conditions, can serve as a framework for healthcare providers to manage peri‐liver transplant hyperglycemia effectively.

28 September 2026 in Journal of Medical Case Reports
Verified
Journal Article
Open access
PDF file
AMAlimohamad Moradi
Alimohamad Moradi
HMHossein Malekee
Hossein Malekee
MFMohammad Sadegh Fakhari
Mohammad Sadegh Fakhari
FSFaeze Salahshour
Faeze Salahshour
Intraductal papillary mucinous neoplasms (IPMNs) of the pancreas are cystic epithelial tumors with variable malignant potential. Mixed-type IPMNs, which in